Ranplan Group (RPLAN) H1 2025 earnings summary

Executive summary

• Net sales rose 5% year-over-year to SEK 6.9 million, but total income declined 8% to SEK 12.8 million due to lower research project income and currency effects.

• Operating loss widened to SEK 8.1 million, with net loss at SEK 9.4 million, attributed to lower research project income, higher operating expenses, and negative FX effects.

• Gross margin remained near 100% due to negligible cost of sales and a pure software licensing model.

• SEK 36 million was raised in a set-off share issue, eliminating all outstanding debt and strengthening the balance sheet.

• Cash at period end was SEK 3.9 million, with a fully unutilised SEK 50 million credit line available and no debt.

Financial highlights

• Net sales increased 5% year-over-year to SEK 6.9 million; total income fell 8% to SEK 12.8 million due to lower research project funding and currency headwinds.

• Operating expenditures rose 3%, mainly from R&D, salary increases, restructuring charges, and seasonal staff additions.

• R&D expenses rose 8% to SEK 12.4 million, making up 60% of OPEX.

• Shareholders' equity improved to SEK 5.6 million from -SEK 13.2 million a year ago after SEK 36 million in share issues.

• Cash flow from operations was -SEK 8.3 million, impacted by timing of tax credit collections.

Outlook and guidance

• No formal guidance provided due to unpredictability of net sales and the significant impact of single deals on results.

• Management aspires to drive efficiencies, expand the customer base, and achieve cash break-even with an incremental USD 2 million in sales.

• Pipeline of business prospects is expanding globally, with new customer wins and contract renewals.

• Exogenous factors, including investment hesitancy and global events, continue to impact demand.